PADMANEE SHARMA to Mice, Transgenic
This is a "connection" page, showing publications PADMANEE SHARMA has written about Mice, Transgenic.
Connection Strength
0.281
-
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner. Cancer Immunol Res. 2019 Nov; 7(11):1803-1812.
Score: 0.096
-
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy. J Clin Invest. 2018 08 31; 128(9):3813-3818.
Score: 0.089
-
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018 04 02; 128(4):1338-1354.
Score: 0.022
-
An increased gamma delta T cell population in the intestine of thymus-leukemia antigen transgenic mice. Cell Immunol. 1997 Mar 15; 176(2):153-7.
Score: 0.020
-
Transgenic mice expressing the thymus leukemia antigen fail to control cutaneous herpes simplex virus infection. Cell Immunol. 1996 Nov 25; 174(1):84-9.
Score: 0.020
-
Thymus-leukemia antigen interacts with T cells and self-peptides. J Immunol. 1996 Feb 01; 156(3):987-96.
Score: 0.019
-
Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014 Jun 16; 25(6):719-34.
Score: 0.017